Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Specifically activated memory T cell subsets from cancer patients recognize and reject xenotransplanted autologous tumors
Philipp Beckhove, … , Volker Schirrmacher, Viktor Umansky
Philipp Beckhove, … , Volker Schirrmacher, Viktor Umansky
Published July 1, 2004
Citation Information: J Clin Invest. 2004;114(1):67-76. https://doi.org/10.1172/JCI20278.
View: Text | PDF
Article Oncology Article has an altmetric score of 3

Specifically activated memory T cell subsets from cancer patients recognize and reject xenotransplanted autologous tumors

  • Text
  • PDF
Abstract

Bone marrow of breast cancer patients was found to contain CD8+ T cells specific for peptides derived from breast cancer–associated proteins MUC1 and Her-2/neu. Most of these cells had a central or effector memory phenotype (CD45RA–CD62L+ or CD45RA–CD62L–, respectively). To test their in vivo function, we separated bone marrow–derived CD45RA+ naive or CD45RA–CD45RO+ memory T cells, stimulated them with autologous dendritic cells pulsed with tumor lysate, and transferred them into NOD/SCID mice bearing autologous breast tumors and normal skin transplants. CD45RA– memory but not CD45RA+ naive T cells infiltrated autologous tumor but not skin tissues after the transfer. These tumor-infiltrating cells had a central or effector memory phenotype and produced perforin. Many of them expressed the P-selectin glycoprotein ligand 1 and were found around P-selectin+ tumor endothelium. Tumor infiltration included cluster formation in tumor tissue by memory T cells with cotransferred dendritic cells. It was associated with the induction of tumor cell apoptosis and significant tumor reduction. We thus demonstrate selective homing of memory T cells to human tumors and suggest that tumor rejection is based on the recognition of tumor-associated antigens on tumor cells and dendritic cells by autologous specifically activated central and effector memory T cells.

Authors

Philipp Beckhove, Markus Feuerer, Mathias Dolenc, Florian Schuetz, Carmen Choi, Nora Sommerfeldt, Jochen Schwendemann, Katrin Ehlert, Peter Altevogt, Gunther Bastert, Volker Schirrmacher, Viktor Umansky

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 Total
Citations: 1 3 1 2 3 4 5 4 4 3 4 2 1 1 4 3 4 4 3 1 57
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (57)

Title and authors Publication Year
Tumor-specific CD8+ T cells from the bone marrow resist exhaustion and exhibit increased persistence in tumor-bearing hosts as compared with tumor-infiltrating lymphocytes
Zawidzka EM, Biavati L, Thomas A, Zanettini C, Marchionni L, Leone R, Borrello I
Journal for Immunotherapy of Cancer 2025
Exploring the evolution of T cell function and diversity across different stages of non-small cell lung cancer
Chang CY, Chang SC, Wei YF, Tseng YT, Chou CH, Chen YY, Chen CY, Ye YL
American journal of cancer research 2024
Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution.
Schirrmacher V, Van Gool S, Stuecker W
Biomedicines 2024
Influence of cryoablation versus operation on circulating lymphocyte subsets in patients with early-stage renal cell carcinoma
Waidhauser J, Gantner AK, Schifano P, Rippel K, Schiele S, Arndt TT, Müller G, Steinestel J, Rank A, Kröncke T
BMC Cancer 2024
Tumor-Specific CD8+ T Cells from the Bone Marrow Resist Exhaustion and Exhibit Increased Persistence in Tumor-Bearing Hosts as Compared to Tumor Infiltrating Lymphocytes
Zawidzka EM, Biavati L, Thomas A, Zanettini C, Marchionni L, Leone R, Borrello I
2023
Effects of Estrogens on Osteoimmunology: A Role in Bone Metastasis
Marie JC, Bonnelye E
Frontiers in immunology 2022
Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy.
Schirrmacher V, van Gool S, Stuecker W
International journal of molecular sciences 2022
Common clonal origin of conventional T cells and induced regulatory T cells in breast cancer patients
M Xydia, R Rahbari, E Ruggiero, I Macaulay, M Tarabichi, R Lohmayer, S Wilkening, T Michels, D Brown, S Vanuytven, S Mastitskaya, S Laidlaw, N Grabe, M Pritsch, R Fronza, K Hexel, S Schmitt, M Müller-Steinhardt, N Halama, C Domschke, M Schmidt, C von Kalle, F Schütz, T Voet, P Beckhove
Nature Communications 2021
Tissue-Resident Memory T Cells in Skin Diseases: A Systematic Review
T Emmanuel, J Mistegård, A Bregnhøj, C Johansen, L Iversen
International journal of molecular sciences 2021
Increased Expression of TICRR Predicts Poor Clinical Outcomes: A Potential Therapeutic Target for Papillary Renal Cell Carcinoma
S Xia, Y Lin, J Lin, X Li, X Tan, Z Huang
Frontiers in Genetics 2021
Unravelling the heterogeneity and dynamic relationships of tumor‐infiltrating T cells by single‐cell RNA sequencing analysis
X Yu, L Zhang, A Chaudhry, AS Rapaport, W Ouyang
Journal of leukocyte biology 2020
Unveiling the immune infiltrate modulation in cancer and response to immunotherapy by MIXTURE—an enhanced deconvolution method
EA Fernández, YD Mahmoud, F Veigas, D Rocha, M Miranda, J Merlo, M Balzarini, HD Lujan, GA Rabinovich, MR Girotti
Briefings in Bioinformatics 2020
Expanding the Spectrum of Adenoviral Vectors for Cancer Therapy
J Gao, W Zhang, A Ehrhardt
Cancers 2020
New Insights into Mechanisms of Long-term Protective Anti-tumor Immunity Induced by Cancer Vaccines Modified by Virus Infection
V Schirrmacher
Biomedicines 2020
Bone marrow expands the repertoire of functional T cells targeting tumor-associated antigens in patients with resectable non-small-cell lung cancer
S Safi, Y Yamauchi, S Stamova, A Rathinasamy, J op den Winkel, S Jünger, M Bucur, L Umansky, A Warth, E Herpel, M Eichhorn, H Winter, H Hoffmann, P Beckhove
OncoImmunology 2019
Striking a Balance—Cellular and Molecular Drivers of Memory T Cell Development and Responses to Chronic Stimulation
JL Hope, CJ Stairiker, EA Bae, DC Otero, LM Bradley
Frontiers in immunology 2019
The Immune Microenvironment Impacts Survival in Western Patients with Gastric Adenocarcinoma
A Uppal, A Dehal, SC Chang, D Barrak, Y Naeini, JR Jalas, AJ Bilchik
Journal of Gastrointestinal Surgery 2019
Immunology of Adenoviral Vectors in Cancer Therapy
AR Shaw, M Suzuki
Molecular Therapy — Methods & Clinical Development 2019
NIX-Mediated Mitophagy Promotes Effector Memory Formation in Antigen-Specific CD8+ T Cells
SS Gupta, R Sharp, C Hofferek, L Kuai, GW Dorn, J Wang, M Chen
Cell Reports 2019
Long-peptide vaccination with driver gene mutations in p53 and Kras induces cancer mutation-specific effector as well as regulatory T cell responses
J Quandt, C Schlude, M Bartoschek, R Will, A Cid-Arregui, S Schölch, C Reissfelder, J Weitz, M Schneider, S Wiemann, F Momburg, P Beckhove
OncoImmunology 2018
FOXOs in cancer immunity: Knowns and unknowns
Y Deng, F Wang, T Hughes, J Yu
Seminars in Cancer Biology 2018
Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma
S Stadler, V Singh, F Knörr, C Damm-Welk, W Woessmann
Cancers 2018
Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment
C Fu, A Jiang
Frontiers in immunology 2018
Functional T cells targeting tumor-associated antigens are predictive for recurrence-free survival of patients with radically operated non-small cell lung cancer
S Safi, Y Yamauchi, A Rathinasamy, S Stamova, M Eichhorn, A Warth, G Rauch, H Dienemann, H Hoffmann, P Beckhove
OncoImmunology 2017
Tumor specific regulatory T cells in the bone marrow of breast cancer patients selectively upregulate the emigration receptor S1P1
A Rathinasamy, C Domschke, Y Ge, HH Böhm, S Dettling, D Jansen, F Lasitschka, L Umansky, MH Gräler, J Hartmann, C Herold-Mende, F Schuetz, P Beckhove
Cancer Immunology, Immunotherapy 2017
Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model
H Jespersen, MF Lindberg, M Donia, EM Söderberg, R Andersen, U Keller, L Ny, IM Svane, LM Nilsson, JA Nilsson
Nature Communications 2017
Impact of the Tumor Microenvironment on Tumor-Infiltrating Lymphocytes: Focus on Breast Cancer
I Cohen, R Blasberg
Breast cancer : basic and clinical research 2017
Bone Marrow T Cells and the Integrated Functions of Recirculating and Tissue-Resident Memory T Cells
FD Rosa, T Gebhardt
Frontiers in immunology 2016
Effector, Memory, and Dysfunctional CD8 + T Cell Fates in the Antitumor Immune Response
J Reiser, A Banerjee
Journal of Immunology Research 2016
Cellular Immune Responses and Immune Escape Mechanisms in Breast Cancer: Determinants of Immunotherapy
C Domschke, A Schneeweiss, S Stefanovic, M Wallwiener, J Heil, J Rom, C Sohn, F Schuetz
Breast Care 2016
T cell responses in early-stage melanoma patients occur frequently and are not associated with humoral response
C Pfirschke, C Gebhardt, I Zörnig, M Pritsch, SB Eichmüller, D Jäger, A Enk, P Beckhove
Cancer Immunology, Immunotherapy 2015
Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trial
FH Schmitz-Winnenthal, N Hohmann, AG Niethammer, T Friedrich, H Lubenau, M Springer, KM Breiner, G Mikus, J Weitz, A Ulrich, MW Buechler, F Pianka, U Klaiber, M Diener, C Leowardi, S Schimmack, L Sisic, AV Keller, R Koc, C Springfeld, P Knebel, T Schmidt, Y Ge, M Bucur, S Stamova, L Podola, WE Haefeli, L Grenacher, P Beckhove
OncoImmunology 2015
CD4 + T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients
D Dubinski, J Wölfer, M Hasselblatt, T Schneider-Hohendorf, U Bogdahn, W Stummer, H Wiendl, OM Grauer
Neuro-Oncology 2015
A randomized phase II study of radiation induced immune boost in operable non-small cell lung cancer (RadImmune trial)
S Safi, P Beckhove, A Warth, A Benner, F Roeder, S Rieken, J Debus, H Dienemann, H Hoffmann, PE Huber
BMC Cancer 2015
In-situ activity of tumor specific CTL determines colorectal cancer prognosis
Christoph Reissfelder, Slava Stamova, Christina Gossmann, Marion Braun, Andreas Bonertz, Ute Walliczek, Mario Grimm, Nuh Rahbari, Moritz Koch, Maral Saadati, Axel Benner, Markus Buechler, Dirk Jäger, Niels Halama, Khashayarsha Khazaie, Jürgen Weitz, Philipp Beckhove
Journal of Clinical Investigation 2014
Common Ewing sarcoma-associated antigens fail to induce natural T cell responses in both patients and healthy individuals.
Altvater B, Kailayangiri S, Theimann N, Ahlmann M, Farwick N, Chen C, Pscherer S, Neumann I, Mrachatz G, Hansmeier A, Hardes J, Gosheger G, Juergens H, Rossig C
Cancer Immunology, Immunotherapy 2014
Long-term survival after adoptive bone marrow T cell therapy of advanced metastasized breast cancer: follow-up analysis of a clinical pilot trial
Domschke C, Ge Y, Bernhardt I, Schott S, Keim S, Juenger S, Bucur M, Mayer L, Blumenstein M, Rom J, Heil J, Sohn C, Schneeweiss A, Beckhove P, Schuetz F
Cancer Immunology, Immunotherapy 2013
Development of immune memory to glial brain tumors after tumor regression induced by immunotherapeutic Toll-like receptor 7/8 activation
A Stathopoulos, C Pretto, L Devillers, D Pierre, FM Hofman, C Kruse, M Jadus, TC Chen, VE Schijns
OncoImmunology 2012
Significance of Heparanase in Cancer and Inflammation
I Vlodavsky, P Beckhove, I Lerner, C Pisano, A Meirovitz, N Ilan, M Elkin
Cancer Microenvironment 2011
Intratumoral Immune Responses Can Distinguish New Primary and True Recurrence Types of Ipsilateral Breast Tumor Recurrences (IBTR)
NR West, V Panet-Raymond, PT Truong, C Alexander, S Babinszky, K Milne, LA Ross, S Loken, PH Watson
Breast cancer : basic and clinical research 2011
Randomized controlled phase I/II study to investigate immune stimulatory effects by low dose radiotherapy in primarily operable pancreatic cancer
C Timke, HS Winnenthal, F Klug, FF Roeder, A Bonertz, C Reissfelder, N Rochet, M Koch, C Tjaden, MW Buechler, J Debus, J Werner, P Beckhove, J Weitz, PE Huber
BMC Cancer 2011
A randomized controlled trial to investigate the influence of low dose radiotherapy on immune stimulatory effects in liver metastases of colorectal cancer
C Reissfelder, C Timke, H Schmitz-Winnenthal, NN Rahbari, M Koch, F Klug, F Roeder, L Edler, J Debus, MW Büchler, P Beckhove, PE Huber, J Weitz
BMC Cancer 2011
Targeting the autophagy pathway for cancer chemoprevention
MA Steeves, FC Dorsey, JL Cleveland
Current Opinion in Cell Biology 2010
Tumor vaccine composed of C-class CpG oligodeoxynucleotides and irradiated tumor cells induces long-term antitumor immunity
P Cerkovnik, BJ Novakovic, V Stegel, S Novakovic
BMC Immunology 2010
Determination of paraneoplastic autoimmune responses by tumor cell biology and intratumoral IFN-alpha/IL-12 in breast cancer patients
C Domschke, F Schuetz, Y Ge, J Rom, M Zorn, HP Sinn, F Marmé, S Schott, J Heil, A Scharf, C Sohn, A Schneeweiss, P Beckhove
Cancer Immunology, Immunotherapy 2010
Antigen-specific Treg in colorectal carcinoma control T cell responses against a limited tumor antigen repertoire
Andreas Bonertz, Dong-Ho Kim Pietsch, Nuh Rabari, Christoph Schlude, Yingzi Ge, Simone Juenger, Israel Vlodavsky, Khashayarsha Khazaie, Moritz Koch, Jürgen Weitz and Philipp Beckhove
Journal of Clinical Investigation 2009
Effects of distant metastasis and peripheral CA 15-3 on the induction of spontaneous T cell responses in breast cancer patients
C Domschke, F Schuetz, N Sommerfeldt, J Rom, A Scharf, C Sohn, A Schneeweiss, P Beckhove
Cancer Immunology, Immunotherapy 2009
High avidity myeloid leukemia-associated antigen-specific CD8+ T cells preferentially reside in the bone marrow
JJ Melenhorst, P Scheinberg, PK Chattopadhyay, E Gostick, K Ladell, M Roederer, NF Hensel, DC Douek, AJ Barrett, DA Price
Blood 2009
High frequencies of less differentiated and more proliferative WT1‐specific CD8+ T cells in bone marrow in tumor‐bearing patients: An important role of bone marrow as a secondary lymphoid organ
Murao A, Oka Y, Tsuboi A, Elisseeva OA, Tanaka\u2010Harada Y, Fujiki F, Nakajima H, Nishida S, Hosen N, Shirakata T, Hashimoto N, Myoui A, Ueda T, Takeda Y, Osaki T, Enomoto T, Yoshikawa H, Kimura T, Oji Y, Kawase I, Sugiyama H
Cancer Science 2009
In vivo functional efficacy of tumor-specific T cells expanded using HLA-Ig based artificial antigen presenting cells (aAPC)
M Durai, C Krueger, Z Ye, L Cheng, A Mackensen, M Oelke, JP Schneck
Cancer Immunology, Immunotherapy 2008
Immunisation with 'naïve' syngeneic dendritic cells protects mice from tumour challenge
MJ Grimshaw, K Papazisis, G Picco, H Bohnenkamp, T Noll, J Taylor-Papadimitriou, J Burchell
British Journal of Cancer 2008
HLA-A2-Restricted Cytotoxic T Lymphocyte Epitopes from Human Heparanase as Novel Targets for Broad-Spectrum Tumor Immunotherapy
Chen T, Tang XD, Wan Y, Chen L, Yu ST, Xiong Z, Fang DC, Liang GP, Yang SM
Neoplasia (New York, N.Y.) 2008
Treatment of advanced metastasized breast cancer with bone marrow-derived tumour-reactive memory T cells: a pilot clinical study
Schuetz F, Ehlert K, Ge Y, Schneeweiss A, Rom J, Inzkirweli N, Sohn C, Schirrmacher V, Beckhove P
Cancer Immunology, Immunotherapy 2008
Principles of Adoptive T Cell Cancer Therapy
Carl H. June
Journal of Clinical Investigation 2007
Tumor immunoediting and immunosculpting pathways to cancer progression
JM Reiman, M Kmieciak, MH Manjili, KL Knutson
Seminars in Cancer Biology 2007
Adoptively transferred human lung tumor specific cytotoxic T cells can control autologous tumor growth and shape tumor phenotype in a SCID mouse xenograft model
E Oflazoglu, M Elliott, H Takita, S Ferrone, RA Henderson, EA Repasky
Journal of Translational Medicine 2007
Tumor infiltrating T lymphocytes in colorectal cancer: Tumor-selective activation and cytotoxic activity in situ
M Koch, P Beckhove, JO Winkel, D Autenrieth, P Wagner, D Nummer, S Specht, D Antolovic, L Galindo, FH Schmitz-Winnenthal, V Schirrmacher, MW Büchler, J Weitz
Annals of Surgery 2006

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 patents
22 readers on Mendeley
See more details